아시아태평양의 바이오제조 바이러스 검출 및 정량화 시장 : 분석과 예측(2023-2032년)

“The Asia-Pacific Biomanufacturing Viral Detection and Quantification Market Expected to Reach $0.28 Billion by 2032.”

Introduction to Asia-Pacific Biomanufacturing Viral Detection and Quantification Market

The Asia-Pacific biomanufacturing viral detection and quantification market was valued at $0.11 billion in 2023 and is anticipated to reach $0.28 billion by 2032, witnessing a CAGR of 10.47% during the forecast period 2023-2032. The biomanufacturing viral detection and quantification market growth is anticipated to be propelled by the increasing use of biopharmaceutical products and the technological advancements in viral testing within the industry.

Market Introduction

The Asia-Pacific (APAC) biomanufacturing viral detection and quantification market is currently advancing at a rapid pace. This growth can be attributed to the increasing adoption of biopharmaceuticals within the region. The stringent need for robust quality control processes to ensure the safety, efficacy, and consistency of biopharmaceutical products is driving the demand for consumables and instruments used in quantifying viral contaminants during the biomanufacturing of biologics. As APAC embraces the biopharmaceutical industry's advancements, the demand for viral detection and quantification solutions is expected to surge. This presents a significant opportunity for manufacturers and providers of biomanufacturing viral detection and quantification products in the APAC market, as they play a pivotal role in ensuring the integrity and safety of biopharmaceutical production processes in the region.

Market Segmentation:

Segmentation 1: by Offering Type

• Consumables
• Instruments
• Services

Segmentation 2: by Technology

• PCR
• ELISA
• Flow Cytometry
• Plaque Assay
• Others

Segmentation 3: by Application

• Blood and Blood Products Manufacturing
• Vaccines and Therapeutics Manufacturing
• Cellular and Gene Therapy Products Manufacturing
• Stem Cell Products Manufacturing
• Tissue and Tissue Products Manufacturing

Segmentation 4: by End User

• Life Science Companies
• Testing Laboratories
• CROs and CDMOs

Segmentation 5: by Country

• China
• Japan
• South Korea
• Australia
• India
• Rest-of-Asia-Pacific

How can this report add value to an organization?

Workflow/Innovation Strategy: The Asia-Pacific biomanufacturing viral detection and quantification market (by offering type) has been segmented into consumables, instruments, and services. Moreover, the study provides the reader with a detailed understanding of the different applications of biomanufacturing viral detection and quantification in raw material preparation, upstream processing, downstream processing, and packaging.

Growth/Marketing Strategy: Biomanufacturing viral detection and quantification is being used for raw material preparation, upstream processing, downstream processing, and packaging. Various companies are providing products and services to aid in the viral testing of various biologic production, which is also the key strategy for market players to excel in the current biomanufacturing viral detection and quantification market.

Competitive Strategy: Key players in the APAC biomanufacturing viral detection and quantification market have been analyzed and profiled in the study, including manufacturers. Moreover, a detailed competitive benchmarking of the players operating in the APAC biomanufacturing viral detection and quantification market has been done to help the reader understand how players stack against each other, presenting a clear market landscape.

Table of Contents

Executive Summary

1. Market Scope

• 1.1. Key Questions Answered in the Report

2. Research Methodology

3. Market Overview

• 3.1. Overview
• 3.2. Current Market Size and Future Growth Potential, $Billion, 2022-2032

4. Industry Outlook

• 4.1. Regulatory Landscape
  • 4.1.1. Legal Requirements and Frameworks in Asia-Pacific
    • 4.1.1.1. Legal Requirements and Framework in Japan

5. Biomanufacturing Viral Detection and Quantification Market: Market Dynamics

• 5.1. Business Drivers
  • 5.1.1. Increasing Utilization of Biopharmaceuticals
  • 5.1.2. Technological Advancements in Viral Detection and Quantification
  • 5.1.3. Impact Analysis
• 5.2. Business Restraints
  • 5.2.1. High Cost of Advanced Viral Detection and Quantification Equipment
  • 5.2.2. Lack of Trained Professionals in the Field of Viral Detection and Quantification
  • 5.2.3. Impact Analysis
• 5.3. Business Opportunities
  • 5.3.1. Increasing Need in Viral Contamination Considerations for the Development of Cell and Gene Therapies

6. Biomanufacturing Viral Detection and Quantification Market (by Region), Value ($Million), 2022-2032

• 6.1. Overview
• 6.2. Asia-Pacific
  • 6.2.1. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
  • 6.2.2. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
  • 6.2.3. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
  • 6.2.4. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)
  • 6.2.5. Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Country)
    • 6.2.5.1. China
      • 6.2.5.1.1. China Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.1.2. China Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.1.3. China Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.1.4. China Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.2. Japan
      • 6.2.5.2.1. Japan Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.2.2. Japan Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.2.3. Japan Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.2.4. Japan Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.3. India
      • 6.2.5.3.1. India Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.3.2. India Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.3.3. India Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.3.4. India Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.4. Australia
      • 6.2.5.4.1. Australia Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.4.2. Australia Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.4.3. Australia Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.4.4. Australia Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.5. South Korea
      • 6.2.5.5.1. South Korea Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.5.2. South Korea Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.5.3. South Korea Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.5.4. South Korea Biomanufacturing Viral Detection and Quantification Market (by End User)
    • 6.2.5.6. Rest-of-Asia-Pacific
      • 6.2.5.6.1. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Offering Type)
      • 6.2.5.6.2. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Technology)
      • 6.2.5.6.3. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by Application)
      • 6.2.5.6.4. Rest-of-Asia-Pacific Biomanufacturing Viral Detection and Quantification Market (by End User)

7. Markets - Competitive Benchmarking & Company Profiles

• 7.1. Overview
• 7.2. Company Share Analysis
• 7.3. Biomanufacturing Viral Detection and Quantification Ecosystem Active Players
• 7.4. TAKARA HOLDINGS INC.
  • 7.4.1. Company Overview
  • 7.4.2. Role of TAKARA HOLDINGS INC. in the Biomanufacturing Viral Detection and Quantification Market
  • 7.4.3. Key Competitors
  • 7.4.4. Financials
  • 7.4.5. Key Insights about the Financial Health of the Company
  • 7.4.6. Analyst Perspective